Precision BioSciences, Inc.

US$10.60As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DTILHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (40.32%)
Div yield —
ROE (115.28%)
Biotechnology
Beta (5Y) 1.35
PE TTM —
TSR TTM 29.90%
Mkt cap US$404.6M
ROIC (36.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$14
27.99%
(71.31%)
Hold 0|6|6|4|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.15
0.15
0.16
0.16
7.82%
10.29%
10.75%
17.69%
Revenue$M
41.26
42.42
43.34
44.48
11.32%
12.54%
11.97%
13.80%
Peers (US$404.6M)
Cap (US$)
PE
407.0M
—
404.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.260
0.023
0.022
EBIT/Intx
5.417
0.530
0.326
Own earn%
192.36
(39.61)
(37.74)
Sh yield%
30.41
8.21
8.27
Owners
Insiders/Inst%
7.09
72.96
Short interest%
5.53
SBC / revenue%
0.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
8–17
$1 testx
−0.1
Incr. ROIC%
7